Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 4/20 | 0.39 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13111163 | 0.89 | HTR6 (0.51) | ALDH1A1GAAHTTHTR6PGR | |
| SCHEMBL3475504 | 0.88 | CA1 (0.50) | CA12CA1CA2CA9 | |
| SCHEMBL13111154 | 0.88 | DRD2 (0.45) | IKBKBALDH1A1GAAHTTHTR6 | |
| SCHEMBL10172234 | 0.84 | HTR6 (0.50) | ALDH1A1GAAHTTHTR6PKM | |
| SCHEMBL13111161 | 0.81 | HTR6 (0.45) | ALDH1A1GAAHTTHTR6 | |
| SCHEMBL13111158 | 0.80 | ALDH1A1 (0.38) | ALDH1A1GAAHTTHTR6PGR | |
| SCHEMBL3474950 | 0.78 | HTR6 (0.51) | HTR6CA12CA1CA2CA9 | |
| SCHEMBL13111172 | 0.78 | KEAP1 (0.48) | ALDH1A1GAAHTT | |
| SCHEMBL13111180 | 0.77 | ALDH1A1 (0.40) | ALDH1A1GAAHTTHTR6 | |
| SCHEMBL13111155 | 0.76 | CA12 (0.49) | ALDH1A1GAAHTTCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100256092-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256092-A1 | BORON-CONTAINING SMALL MOLECULES | BCL6B, BCL6, BTD | IKBKB 399/4885ALDH1A1 4190/4885GAA 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.